Brian Gray, DO
Family Medicine · Murfreesboro, TNNPI 1003293028
Payments from drug & device makers
Across 451 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$983
- Pfizer$858
- Lilly USA, LLC$714
- Otsuka America Pharmaceutical, Inc.$504
- AbbVie$481
- AstraZeneca$467
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,997100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $983 |
| Pfizer | 48 | $858 |
| Lilly USA, LLC | 54 | $714 |
| Otsuka America Pharmaceutical, Inc. | 32 | $504 |
| AbbVie | 28 | $481 |
| AstraZeneca(2 entities) | 29 | $467 |
| GSK | 24 | $448 |
| Boehringer Ingelheim | 24 | $436 |
| Amgen(2 entities) | 25 | $400 |
| Astellas Pharma US Inc | 20 | $365 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $231 |
| Merck | 13 | $198 |
| Bayer | 6 | $105 |
| Esperion Therapeutics, Inc. | 5 | $93 |
| Johnson & Johnson | 5 | $82 |
| Dynavax Technologies Corporation | 5 | $82 |
| Idorsia Pharmaceuticals US Inc | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Lundbeck LLC | 2 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $39 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Eisai Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $21 |
| Novartis | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 2 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Gilead | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$6,997 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $50,034 |
| JardianceEmpagliflozin | 35 | $34,687 |
| EliquisApixaban | 30 | $26,905 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $23,105 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $9,961 |
| Rosuvastatin Calcium | 265 | $3,298 |
| Atorvastatin Calcium | 225 | $2,613 |
| Losartan Potassium | 149 | $1,870 |
| Duloxetine Hcl | 70 | $1,816 |
| Levothyroxine Sodium | 191 | $1,768 |
| Pantoprazole Sodium | 108 | $1,640 |
| Omeprazole | 95 | $1,565 |
| Tamsulosin Hcl | 64 | $1,371 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,254 |
| SsdSilver Sulfadiazine | 13 | $1,135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $983 | $50,03429 claims |
| Boehringer IngelheimJardiance | $436 | $34,68735 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $448 | $33,06639 claims |
| PfizerEliquis | $858 | $26,90530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Murfreesboro
- Scott EllerMurfreesboro$17K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.